The Veterinary Endocrinology Market is Predict to reach USD 482.2 Million by 2031, at a CAGR of 6.6%

Veterinary Endocrinology Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Veterinary Endocrinology Market size is expected to reach $482.2 billion by 2031, rising at a market growth of 6.6% CAGR during the forecast period.

The Others segment is anticipating a CAGR of 7.2% during (2024 - 2031). Some animals may have difficulty tolerating oral medications due to gastrointestinal issues, taste aversion, or difficulty swallowing pills. Alternative routes of administration, such as injectable formulations or transdermal patches, provide viable options for delivering medications to animals who cannot effectively receive treatment orally. Different routes of administration offer flexibility in treatment options, allowing veterinarians to tailor therapy to each animal's needs.

The Dogs segment is leading the Global Veterinary Endocrinology Market by Animal Type in 2023; thereby, achieving a market value of $280.5 million by 2031. Certain endocrine disorders, such as diabetes mellitus, hypothyroidism, and hyperadrenocorticism (Cushing’s disease), are more commonly diagnosed in dogs compared to other species. These conditions are prevalent, especially in middle-aged to older dogs, driving the demand for specialized endocrinology services. Dogs are among the most popular pets globally, with many pet owners and a significant household presence.

The Others segment is registering a CAGR of 7% during (2024 - 2031). There is growing awareness and improved diagnostic capabilities for a wide range of endocrine disorders in companion animals. Veterinarians are better equipped to recognize and diagnose conditions such as adrenal disorders, reproductive hormone imbalances, calcium metabolism disorders, and growth hormone abnormalities.

Full Report: https://www.kbvresearch.com/veterinary-endocrinology-market/

The North America region dominated the Global Veterinary Endocrinology Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $181.3 million by 2031. The Europe region is experiencing a CAGR of 6.4% during (2024 - 2031). Additionally, The Asia Pacific region would showcase a CAGR of 7.2% during (2024 - 2031).

List of Key Companies Profiled

• Dechra Pharmaceuticals PLC (EQT AB)
• Elanco Animal Health Incorporated
• Merck & Co., Inc.
• Boehringer Ingelheim International GmbH
• Zoetis, Inc.
• LLOYD, Inc.
• Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
• Mars, Inc. (Antech Diagnostics, Inc)

Veterinary Endocrinology Market Report Segmentation

By Route of Administration

• Oral and
• Other routes

By Animal Type

• Dogs,
• Cats, and
• Other Animals

By Application

• Pancreatic Disorders, and
• Other Disorders

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Related Reports:

North America Veterinary Endocrinology Market Size to 2031

• July-2024
• 99 Pages

LAMEA Veterinary Endocrinology Market Size | Analysis 2031

• July-2024
• 107 Pages

Europe Veterinary Endocrinology Market Size | Forecast 2031

• July-2024
• 109 Pages

Asia Pacific Veterinary Endocrinology Market Size, Share 2031

• July-2024
• 111 Pages